Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Zoledronic Acid in Chordoma: NCT06625190 Clinical Landscape Report 2026
15 October 2026
NCT06625190 clinical landscape for Chordoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ATX-559 in Mismatch repair-deficient Endometrial Carcinoma: NCT06625515 Clinical Landscape Report 2026
15 October 2026
NCT06625515 clinical landscape for Mismatch repair-deficient Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
LNS-8801 in Melanoma, Cutaneous Malignant: NCT06624644 Clinical Landscape Report 2026
15 October 2026
NCT06624644 clinical landscape for Melanoma, Cutaneous Malignant: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tebentafusp in Uveal Melanoma: NCT06626516 Clinical Landscape Report 2026
15 October 2026
NCT06626516 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tebentafusp in Uveal Melanoma: NCT06627244 Clinical Landscape Report 2026
15 October 2026
NCT06627244 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NECVAXNEO1 in Triple Negative Breast Cancer: NCT06631092 Clinical Landscape Report 2026
15 October 2026
NCT06631092 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ANV-419 in Non-Small Cell Lung Cancer: NCT06630611 Clinical Landscape Report 2026
15 October 2026
NCT06630611 clinical landscape for Non-Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tamoxifen Citrate in Ovarian Cancer: NCT06630325 Clinical Landscape Report 2026
15 October 2026
NCT06630325 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Temozolomide in Astrocytoma: NCT06630260 Clinical Landscape Report 2026
15 October 2026
NCT06630260 clinical landscape for Astrocytoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CBA-1205 in Hepatocellular Carcinoma: NCT06636435 Clinical Landscape Report 2026
15 October 2026
NCT06636435 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Meningioma: NCT06640582 Clinical Landscape Report 2026
15 October 2026
NCT06640582 clinical landscape for Meningioma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PTT-4256 in Solid tumor: NCT06634849 Clinical Landscape Report 2026
15 October 2026
NCT06634849 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.